Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 3
1949 2
1950 3
1951 7
1952 3
1953 1
1954 3
1955 2
1956 1
1959 1
1963 1
1968 2
1969 1
1979 1
1980 1
1984 1
1985 1
1987 2
1988 1
1989 1
1990 2
1991 2
1992 4
1993 6
1994 5
1995 3
1996 1
1997 3
1998 1
1999 1
2000 4
2001 4
2002 5
2003 3
2004 2
2005 6
2006 5
2007 5
2008 3
2009 9
2010 2
2011 5
2012 7
2013 10
2014 6
2015 10
2016 8
2017 19
2018 16
2019 16
2020 10
2021 15
2022 16
2023 20
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Results by year

Filters applied: . Clear all
Page 1
Response.
MacDonald MI, Osadnik CR, Leong P, King PT, Bardin PG. MacDonald MI, et al. Among authors: bardin pg. Chest. 2019 Dec;156(6):1277-1278. doi: 10.1016/j.chest.2019.08.2177. Chest. 2019. PMID: 31812203 No abstract available.
Reply.
Leong P, Hull JH, Gibson PG, Halvorsen T, Bardin PG; VCD/ILO Delphi Steering Committee. Leong P, et al. Among authors: bardin pg. J Allergy Clin Immunol. 2023 Dec;152(6):1688-1689. doi: 10.1016/j.jaci.2023.08.027. Epub 2023 Sep 20. J Allergy Clin Immunol. 2023. PMID: 37737751 No abstract available.
Nurturing Respirology.
Bardin P, Reynolds PN. Bardin P, et al. Respirology. 2019 Feb;24(2):92. doi: 10.1111/resp.13466. Respirology. 2019. PMID: 30636382 No abstract available.
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.
Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, Stewart PW, Suissa S, Adjei AA, Akdis CA, Azoulay É, Bakker J, Ballas ZK, Bardin PG, Barreiro E, Bellomo R, Bernstein JA, Brusasco V, Buchman TG, Chokroverty S, Collop NA, Crapo JD, Fitzgerald DA, Hale L, Hart N, Herth FJ, Iwashyna TJ, Jenkins G, Kolb M, Marks GB, Mazzone P, Moorman JR, Murphy TM, Noah TL, Reynolds P, Riemann D, Russell RE, Sheikh A, Sotgiu G, Swenson ER, Szczesniak R, Szymusiak R, Teboul JL, Vincent JL. Lederer DJ, et al. Among authors: bardin pg. Ann Am Thorac Soc. 2019 Jan;16(1):22-28. doi: 10.1513/AnnalsATS.201808-564PS. Ann Am Thorac Soc. 2019. PMID: 30230362 Free article. No abstract available.
Asthma research priorities: Listening to everybody.
Hancox RJ, Bardin PG. Hancox RJ, et al. Among authors: bardin pg. Respirology. 2023 Jul;28(7):592-593. doi: 10.1111/resp.14522. Epub 2023 May 22. Respirology. 2023. PMID: 37218110 No abstract available.
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
Thomas D, McDonald VM, Stevens S, Harvey ES, Baraket M, Bardin P, Bowden JJ, Bowler S, Chien J, Chung LP, Gillman A, Hew M, Hodge S, James A, Jenkins C, Katelaris CH, Katsoulotos GP, Langton D, Lee J, Marks G, Peters M, Radhakrishna N, Reynolds PN, Rimmer J, Sivakumaran P, Upham JW, Wark P, Yang IA, Gibson PG. Thomas D, et al. Among authors: bardin p. Allergy. 2024 Feb;79(2):384-392. doi: 10.1111/all.15867. Epub 2023 Aug 25. Allergy. 2024. PMID: 37632144
Respirology and the Asia-Pacific Century.
Bardin P, Reynolds P. Bardin P, et al. Respirology. 2017 Jan;22(1):7-8. doi: 10.1111/resp.12953. Epub 2016 Nov 27. Respirology. 2017. PMID: 27889938 Free article. No abstract available.
Clinical Translation of Basic Science in Asthma.
Bardin PG, Foster PS. Bardin PG, et al. N Engl J Med. 2021 Oct 28;385(18):1714-1717. doi: 10.1056/NEJMe2114472. N Engl J Med. 2021. PMID: 34706176 No abstract available.
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.
Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, Murphy K, Maspero JF, O'Brien C, Korn S. Castro M, et al. Among authors: bardin p. Lancet Respir Med. 2015 May;3(5):355-66. doi: 10.1016/S2213-2600(15)00042-9. Epub 2015 Feb 23. Lancet Respir Med. 2015. PMID: 25736990 Clinical Trial.
Exploring united airways.
Bardin PG, Holmes PW, Hamilton G. Bardin PG, et al. Respirology. 2013 Aug;18(6):893-4. doi: 10.1111/resp.12135. Respirology. 2013. PMID: 23730904 Free article. No abstract available.
256 results